Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mark Jesky"'
Autor:
Mark Jesky, Paul Cockwell, Anthony Fenton, Punit Yadav, Stephen Harding, Charles J. Ferro, Rachel Webster, Indranil Dasgupta, Iain L. C. Chapple, Stephanie Stringer
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 5, p e0197043 (2018)
PLoS ONE, Vol 13, Iss 5, p e0197043 (2018)
BACKGROUND Patients with chronic kidney disease (CKD) are at an increased risk of developing end-stage renal disease (ESRD). We assessed for the first time whether urinary free light chains (FLC) are independently associated with risk of ESRD in pati
Autor:
Daniel Guldager Kring Rasmussen, Anthony Fenton, Morten A. Karsdal, Mark Jesky, Paul Cockwell, Signe Holmh Nielsen, Federica Genovese, Susanne Brix, Charles J. Ferro
Publikováno v:
Holm Nielsen, S, Guldager Kring Rasmussen, D, Brix, S, Fenton, A, Jesky, M, Ferro, C J, Karsdal, M, Genovese, F & Cockwell, P 2018, ' A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease ', PLOS ONE, vol. 13, no. 10, e0204239 . https://doi.org/10.1371/journal.pone.0204239
Nielsen, S H, Rasmussen, D G K, Brix, S, Fenton, A, Jesky, M, Ferro, C J, Karsdal, M, Genovese, F & Cockwell, P 2018, ' A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease ', PLOS ONE, vol. 13, no. 10, e0204239 . https://doi.org/10.1371/journal.pone.0204239
PLoS ONE
PLoS ONE, Vol 13, Iss 10, p e0204239 (2018)
Nielsen, S H, Rasmussen, D G K, Brix, S, Fenton, A, Jesky, M, Ferro, C J, Karsdal, M, Genovese, F & Cockwell, P 2018, ' A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease ', PLOS ONE, vol. 13, no. 10, e0204239 . https://doi.org/10.1371/journal.pone.0204239
PLoS ONE
PLoS ONE, Vol 13, Iss 10, p e0204239 (2018)
Background: Patients with chronic kidney disease (CKD) have increased risk of development of endstage renal disease (ESRD) and early mortality. Fibrosis is the central pathogenic process in CKD and is caused by dysregulated extracellular matrix (ECM)